ProBioGen, Immunogenesis in cell line development agreement
Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.
Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.
Health Canada marked the first positive nod to ViiV for its once-monthly HIV regimen, following rejection by the US FDA.
In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country.
The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic.
The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases.
Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide.